Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

One ST3P Further: Optimizing Transition Care for Pediatric Sickle Cell Patients at Atrium Health

Lakisha E Frye, Mehgan Beverley, Payal Desai, Amina Rafique, Kristina Harrell, Megan Lattanze, Jennifer Cornette, Padmaja Veeramreddy

Blood (2024) 144 (Supplement 1): 3624.

https://doi.org/10.1182/blood-2024-210387

Published: 2024

Journal Articles

Establishing a Definition of Transition of Care in Sickle Cell Disease: National Alliance of Sickle Cell Disease Centers Consensus

Stephanie H. Guarino, Akshat Jain, Mohan Madisetti, Kenneth Rivlin, Payal Desai, Robert Hagar, Julie Kanter, Sophie Lanzkron, Deepa Manwani

Blood (2024) 144 (Supplement 1): 3622.

https://doi.org/10.1182/blood-2024-207698

Published: 2024

Journal Articles

Designing and Implementing a Standardized Electronic Health Record (EHR) Template for Transition of Care in Sickle Cell Disease (SCD)

Stephanie H. Guarino, Robin E Miller, Kenneth Rivlin, Mohan Madisetti, Akshat Jain, Jerome A Osheroff, Payal Desai, Julie Kanter, Sophie Lanzkron

Blood (2024) 144 (Supplement 1): 7548.

https://doi.org/10.1182/blood-2024-207769

Published: 2024

Journal Articles

Infusion Immediate Care: Improving Hematology/Oncology Practice Quality through Expanded and Timely Access to Infusion Care

Melissa Barnes, Christina Villa, Brenda Crump, Donna Field, Seungjean Chai, Ruben A. Mesa, Payal Desai, Sridhar Pal, Jennifer Gray, Brittany Knick Ragon

Blood (2024) 144 (Supplement 1): 3675.

https://doi.org/10.1182/blood-2024-200106

Published: 2024

Journal Articles

Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study

Biree Andemariam, Henny H. Billett, William B Ershler, Shayla Bergmann, Vishwas S. Sakhalkar, Alicia Chang, Payal Desai, Nirmish Shah, Sharon Pennington, Robin E. Miller, Laura M. Decastro, Michelle Xu, Brooke Hayward, Ching-Ray Yu, Darla K. Liles

Blood (2023) 142 (Supplement 1): 2499.

https://doi.org/10.1182/blood-2023-188746

Published: 2023

Journal Articles

Quality of Care Among Emerging Adults with Sickle Cell Disease Using the Ascq-ME Qoc Measure: Baseline ST3P-up Study Data Results

Ifeyinwa Osunkwo, Myra Robinson, Anya Griffin, Azizi Coleman, Sharvil Desai, Padmaja Veeramreddy, Payal Desai, Charity Patterson, James Symanowski, Paulette Bryant, Jennifer Cornette, Wally R Smith, James R Eckman, Ramona Lawrence

Blood (2023) 142 (Supplement 1): 5048.

https://doi.org/10.1182/blood-2023-186835

Published: 2023

Journal Articles

Predictive Capacity of Plasma and Urinary Biomarkers for Persistent Albuminuria in Patients with Sickle Cell Disease

Laila Elsherif, Vimal K. Derebail, Yihan Tang, Lara C. Scott, Kammie L. Patillo, David Wichlan, Kristina Landes, Paula McCune, Laura R. Loehr, Payal Desai, Robert Cronin, Laura Y. Zhou, Fei Zou, Jianwen Cai, David M. Pollock, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 3897.

https://doi.org/10.1182/blood-2023-187610

Published: 2023

Journal Articles

Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study

Julie Kanter, Parth Patwari, Payal Desai, Kenneth I. Ataga, Shelley E. Crary, Sophie Lanzkron, Joshua Field, Yu-Che Chung, Linda T. Wang, Björn Mellgård, Van Anh (Vika) Nguyen, Victor R. Gordeuk

Blood (2023) 142 (Supplement 1): 149.

https://doi.org/10.1182/blood-2023-189090

Published: 2023

Journal Articles

Correlation of a Shape Factor and Degree of Saturation of Sickle Cell Red Blood Cells to Vaso-Occulsive Episodes in Sickle Cell Disease

Jeffrey Chalmers, Jacob Strayer, Xian Wu, Hyeon Choe, Mitchell Weigand, Kristina Landes, Jenifer Gomez-PAstora, Andre Francis Palmer, Maciej Zborowski, Payal Desai

Blood (2023) 142 (Supplement 1): 3883.

https://doi.org/10.1182/blood-2023-190311

Published: 2023

Journal Articles

Implementing a Structured Health Care Transition (HCT) Process for Sickle Cell Disease Using Quality Improvement: Results from the Sickle Cell Trevor Thompson Transition Project HCT Learning Collaborative

Ifeyinwa Osunkwo, Jennifer Cornette, Cheryl Courtlandt, Myra Robinson, Patience White, Margaret McManus, Laura Noonan, Payal Desai, Charity Patterson, James R. Eckman, Ramona Lawrence

Blood (2023) 142 (Supplement 1): 248.

https://doi.org/10.1182/blood-2023-187815

Published: 2023

Journal Articles

Patterns of Emergency Department Utilization of Adolescents and Young Adults Living with Sickle Cell in North Carolina

Samuel Wilson, Wei Pan, Olu Jegede, Sarah Leonard, Payal Desai, Daniel Hatch, Camila Reyes, Paula Jean Tanabe, Tyra Girdwood, Shelby Weeks, Mariam Kayle

Blood (2023) 142 (Supplement 1): 5107.

https://doi.org/10.1182/blood-2023-188156

Published: 2023

Journal Articles

Persistent Albuminuria and Chronic Kidney Disease in Adults with Sickle Cell Disease: Results from a Multicenter Natural History Study

Vimal K. Derebail, Laura Y. Zhou, Yihan Tang, Laila Elsherif, Kammie L. Patillo, David Wichlan, Kristina Landes, Paula McCune, Laura R. Loehr, Payal Desai, Robert Cronin, Jianwen Cai, Kenneth I. Ataga

Blood (2023) 142 (Supplement 1): 1124.

https://doi.org/10.1182/blood-2023-179675

Published: 2023

Journal Articles

Management of Malignancies in Patients with Sickle Cell Disease

Saumya Easaw, Ferdous Ahmed, Michelle L. Wallander, Mariam Kayle, Ted Wun, Payal Desai

Blood (2023) 142 (Supplement 1): 5264.

https://doi.org/10.1182/blood-2023-189861

Published: 2023

Journal Articles

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

Carlton D. Dampier, Marilyn Jo Telen, Ted Wun, R. Clark Brown, Payal Desai, Fuad El Rassi, Beng Fuh, Julie Kanter, Yves Pastore, Jennifer Rothman, James G. Taylor, VI, David Readett, Krupa M. Sivamurthy, Brinda Tammara, Li-Jung Tseng, Jay Nelson Lozier, Helen Thackray, John L. Magnani, Kathryn L. Hassell

Blood (2023) 141 (2): 168–179.

https://doi.org/10.1182/blood.2022015797

Published: 2023

Includes: Supplemental data

Journal Articles

The Effect of Individualized Pain Plans for Patients with Sickle Cell Disease on Emergency Provider Satisfaction: A Win for the Patient Can be a Win for the Provider

Sherraine Della-Moretta, Rui Li, David Way, Michael G (MD) Purcell, Melanie Heinlein, Eric Adkins, Luca Delatore, Payal Desai, Ying Huang

Blood (2021) 138 (Supplement 1): 1889.

https://doi.org/10.1182/blood-2021-151771

Published: 2021

Journal Articles

Risk Factors for Adverse Maternal and Fetal Outcomes in Pregnant Patients with Sickle Cell Disease

Sherraine Della-Moretta, William Marshall, Rui Li, Erin Cleary, Philip Samuels, Sarabh Rajpal, Payal Desai

Blood (2021) 138 (Supplement 1): 3117.

https://doi.org/10.1182/blood-2021-151914

Published: 2021

Journal Articles

Early Evaluation of the Use of Crizanlizumab in Sickle Cell Disease: A National Alliance of Sickle Cell Centers Study

Julie Kanter, Gerhard Hellemann, Alice J. Cohen, Deepa Manwani, Modupe Idowu, Stephanie Guarino, Sana Saif Ur Rehman, Marsha Treadwell, E. Leila Jerome Clay, Amma Owusu-Ansah, Jane A. Little, Payal Desai, Mohan Madisetti, Sophie M. Lanzkron

Blood (2021) 138 (Supplement 1): 3113.

https://doi.org/10.1182/blood-2021-153136

Published: 2021

Journal Articles

Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis

Carlton D. Dampier, MD, Marilyn J. Telen, MD, Ted Wun, MD, Wally R Smith, MD, R. Clark Brown, MD PhD, Payal Desai, MD, Fuad A El Rassi, MD, Julie Kanter, MD, Beng R. Fuh, MD, Yves D. Pastore, MD, Jennifer A. Rothman, MD, James G. Taylor, MD, David Readett, BM, BS, MRCP, Jay N Lozier, MDPhD, John L. Magnani, PhD, Helen M Thackray, MD, Kathryn L. Hassell, MD

Blood (2020) 136 (Supplement 1): 18–19.

https://doi.org/10.1182/blood-2020-134803

Published: 2020

Journal Articles

The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD

Alexandra Boye-Doe, Elizabeth Brown, Charu Puri-Sharma, MS, Anjulika Chawla, MD, Joshua J Field, Lynne D. Neumayr, MD, Susan Padrino, MD, Payal Desai, MD, Deepa Manwani, MD, Sophie M. Lanzkron, MD MHS, Jane A. Little, MD

Blood (2020) 136 (Supplement 1): 34–36.

https://doi.org/10.1182/blood-2020-138895

Published: 2020

Journal Articles

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic

Jennifer G. Davila, MD, W. Beau Mitchell, MD, Kerry A Morrone, MD, Ellen J Silver, PhD, Caterina P Minniti, MD, Henny H. Billett, MD MSc, Payal Desai, MD, Sarah H. O'Brien, MD, Deepa Manwani, MD

Blood (2020) 136 (Supplement 1): 38–39.

https://doi.org/10.1182/blood-2020-137071

Published: 2020

NARROW

One ST3P Further: Optimizing Transition Care for Pediatric Sickle Cell Patients at Atrium Health

Establishing a Definition of Transition of Care in Sickle Cell Disease: National Alliance of Sickle Cell Disease Centers Consensus

Designing and Implementing a Standardized Electronic Health Record (EHR) Template for Transition of Care in Sickle Cell Disease (SCD)

Infusion Immediate Care: Improving Hematology/Oncology Practice Quality through Expanded and Timely Access to Infusion Care

Real-World Experience of Individuals with Sickle Cell Disease Treated with Voxelotor: Initial Report from the Multicenter, Prospective Prospect Study

Quality of Care Among Emerging Adults with Sickle Cell Disease Using the Ascq-ME Qoc Measure: Baseline ST3P-up Study Data Results

Predictive Capacity of Plasma and Urinary Biomarkers for Persistent Albuminuria in Patients with Sickle Cell Disease

Safety and Pharmacokinetics of Recombinant ADAMTS13 in Patients with Sickle Cell Disease: A Phase 1 Randomized, Double-Blind, Placebo-Controlled Study

Correlation of a Shape Factor and Degree of Saturation of Sickle Cell Red Blood Cells to Vaso-Occulsive Episodes in Sickle Cell Disease

Implementing a Structured Health Care Transition (HCT) Process for Sickle Cell Disease Using Quality Improvement: Results from the Sickle Cell Trevor Thompson Transition Project HCT Learning Collaborative

Patterns of Emergency Department Utilization of Adolescents and Young Adults Living with Sickle Cell in North Carolina

Persistent Albuminuria and Chronic Kidney Disease in Adults with Sickle Cell Disease: Results from a Multicenter Natural History Study

Management of Malignancies in Patients with Sickle Cell Disease

A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis

The Effect of Individualized Pain Plans for Patients with Sickle Cell Disease on Emergency Provider Satisfaction: A Win for the Patient Can be a Win for the Provider

Risk Factors for Adverse Maternal and Fetal Outcomes in Pregnant Patients with Sickle Cell Disease

Early Evaluation of the Use of Crizanlizumab in Sickle Cell Disease: A National Alliance of Sickle Cell Centers Study

Early Initiation of Treatment with Rivipansel for Acute Vaso-Occlusive Crisis in Sickle Cell Disease (SCD) Achieves Earlier Discontinuation of IV Opioids and Shorter Hospital Stay: Reset Clinical Trial Analysis

The Grndad Registry: Contemporary Natural History Data and an Analysis of Real-World Patterns of Use and Limitations of Disease Modifying Therapy in Adults with SCD

Venous Thromboembolism Prophylaxis Practices for Patients with Sickle Cell Disease Pre and during the COVID-19 Pandemic

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only